183 related articles for article (PubMed ID: 17182752)
21. Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
Guadalupe M; Pollock BH; Westbrook S; Redding S; Bullock D; Anstead G; Agan BK; Marconi VC; Barbieri S; Sankar V; Rebeles J; Flahive Y; Schoolfield J; Wang L; Lei X; Dow D; Yeh CK; Dang H; Infante AJ; Gao SJ
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):83-90. PubMed ID: 21084997
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
[TBL] [Abstract][Full Text] [Related]
23. Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.
Laney AS; Peters JS; Manzi SM; Kingsley LA; Chang Y; Moore PS
J Clin Microbiol; 2006 Oct; 44(10):3734-41. PubMed ID: 17021103
[TBL] [Abstract][Full Text] [Related]
24. Sexual transmission and the natural history of human herpesvirus 8 infection.
Martin JN; Ganem DE; Osmond DH; Page-Shafer KA; Macrae D; Kedes DH
N Engl J Med; 1998 Apr; 338(14):948-54. PubMed ID: 9521982
[TBL] [Abstract][Full Text] [Related]
25. No detectable human herpesvirus-8 oral shedding in seronegative-healthy, immunocompetent individuals from non-endemic regions for Kaposi's sarcoma: A pilot study.
Tozetto-Mendoza TR; Sumita LM; Palmieri M; Ornaghi M; do Canto AM; Braz-Silva PH
J Investig Clin Dent; 2018 Feb; 9(1):. PubMed ID: 28631891
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.
Miller G; Rigsby MO; Heston L; Grogan E; Sun R; Metroka C; Levy JA; Gao SJ; Chang Y; Moore P
N Engl J Med; 1996 May; 334(20):1292-7. PubMed ID: 8609946
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay.
Olsen SJ; Sarid R; Chang Y; Moore PS
J Infect Dis; 2000 Jul; 182(1):306-10. PubMed ID: 10882613
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of antibodies to human herpesvirus-8 in populations with and without risk for infection in São Paulo State.
Souza VA; Sumita LM; Freire W; Sato HK; Grandi JL; Pierrotti LC; Nascimento MC; Pannuti CS
Braz J Med Biol Res; 2004 Jan; 37(1):123-7. PubMed ID: 14689053
[TBL] [Abstract][Full Text] [Related]
29. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
Caterino-de-Araujo A; Magri MC; Manuel RC
J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
[TBL] [Abstract][Full Text] [Related]
30. Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.
Biggar RJ; Engels EA; Whitby D; Kedes DH; Goedert JJ
J Infect Dis; 2003 Jan; 187(1):12-8. PubMed ID: 12508141
[TBL] [Abstract][Full Text] [Related]
31. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
[TBL] [Abstract][Full Text] [Related]
32. Human herpesvirus-8 (HHV-8) antibodies in women from São Paulo, Brazil. Association with behavioral factors and Kaposi's sarcoma.
Caterino-De-Araujo A; de los Santos-Fortuna E; Carbone PH; Cibella SE; Moreira AA
Braz J Infect Dis; 2003 Dec; 7(6):395-401. PubMed ID: 14636479
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of, and risk factors for Kaposi's sarcoma-associated herpesvirus infection among blood donors in Brazil: a multi-center serosurvey.
Nascimento MC; de Souza VA; Sumita LM; Freire W; Weiss HA; Sabino EC; Franceschi S; Pannuti CS; Mayaud P
J Med Virol; 2008 Jul; 80(7):1202-10. PubMed ID: 18461622
[TBL] [Abstract][Full Text] [Related]
34. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
Kedes DH; Lagunoff M; Renne R; Ganem D
J Clin Invest; 1997 Nov; 100(10):2606-10. PubMed ID: 9366576
[TBL] [Abstract][Full Text] [Related]
35. Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma.
Tanzi E; Zappa A; Caramaschi F; Amendola A; Lasagna D; Gatti L; Ascoli V; Rezza G; Zanetti AR
J Med Virol; 2005 Aug; 76(4):571-5. PubMed ID: 15977229
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel.
Iscovich J; Fischbein A; Fisher-Fischbein J; Freedman LS; Eng SM; Boffetta P; Vudovich A; Glasman C; Goldschmidt R; Livingston M; Heger-Maslansky B; Brennan P; Moore PS
Anticancer Res; 2000; 20(3B):2119-22. PubMed ID: 10928163
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
Lennette ET; Blackbourn DJ; Levy JA
Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
Okroj M; Tedeschi R; Mancuso R; Brambilla L; Tourlaki A; Dillner J; Blom AM
Vaccine; 2011 Feb; 29(6):1129-34. PubMed ID: 21134448
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma.
Gao SJ; Alsina M; Deng JH; Harrison CR; Montalvo EA; Leach CT; Roodman GD; Jenson HB
J Infect Dis; 1998 Sep; 178(3):846-9. PubMed ID: 9728556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
